Email Us
songxu@nanocuetech.com
About Us
Molecular Imaging Corporation, headquartered in Tempe, Arizona, was founded in the mid-1990s by Dr. Stuart Lindsay and Dr. Tianwei Jing. Dr. Lindsay, a distinguished physicist and researcher at Arizona State University, brought decades of expertise in nanotechnology and
scanning probe microscopy to the company. Dr. Jing, a highly skilled scientist and entrepreneur, complemented this with his deep knowledge of atomic force microscopy (AFM) and its practical applications in advanced scientific research. Together, they envisioned a company that would push the boundaries of nanoscale imaging and analysis.
The company specialized in designing and manufacturing innovative atomic force microscopy systems, tailored to meet the unique needs of researchers in nanotechnology, life sciences, and materials science. Molecular Imaging’s products were celebrated for their user-friendly interfaces, modular designs, and exceptional precision, enabling
scientists to investigate nanoscale structures, molecular interactions, and surface properties with unparalleled clarity. Their AFM systems were widely adopted for their versatility and ability to support complex experimental setups.
In 2006, Molecular Imaging was acquired by Agilent Technologies (now Keysight Technologies), marking a significant milestone in its journey. This acquisition integrated the founders’ expertise and innovations into Agilent’s broader scientific instrumentation portfolio, continuing the company’s legacy of advancing nanoscale research. However, in 2018, Keysight Technologies announced its withdrawal from the AFM market due to declining demand and a strategic shift in focus. This decision created a significant void for researchers who relied on the precision and reliability of Molecular Imaging’s AFM systems.
Recognizing the need to continue the legacy of innovation and support, a group of former Molecular Imaging and Agilent employees came together to establish a new Molecular Imaging. The team, organized by Dr. Song Xu, former Application Scientist, led by Steve Raba, Chief Technology Officer and former production manager, included John Alexander, senior electrical engineer, Klaus Vicaro, AFM engineer, and John Ris, mechanical engineer.
Dr. Stuart Lindsay also joined as an academic advisor, contributing his wealth of knowledge and vision. Together, this group of experts in application support, production, engineering, and R&D sought to revive the original Molecular Imaging strategy. The new Molecular Imaging remains committed to building advanced AFM systems that are modular, flexible, and designed to meet the diverse needs of researchers. These systems offer unmatched precision, ease of use, and the ability to support highly specialized experimental setups, enabling scientists to explore nanoscale phenomena with clarity and confidence.
By combining state-of-the-art technology with a focus on collaboration and exceptional customer support, the new Molecular Imaging is proud to uphold the legacy of its founders. The team continues to empower breakthroughs in nanotechnology, life sciences, and materials research—just as Molecular Imaging has done since its inception.